Wogonin as a Targeted Therapeutic Agent for EBV (+) Lymphoma Cells Involved in LMP1/NF-κB/miR-155/PU.1 Pathway
BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3145-4
Full Text
Open PDFAbstract
Available in full text
Date
February 21, 2017
Authors
Publisher
Springer Science and Business Media LLC